HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaaki Kitahara Selected Research

Fatty Acids (Saturated Fatty Acids)

7/2020Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaaki Kitahara Research Topics

Disease

16Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2007
13Neoplasms (Cancer)
01/2022 - 01/2007
3Fibrosis (Cirrhosis)
09/2020 - 10/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 04/2019
2Melanoma (Melanoma, Malignant)
10/2020 - 11/2018
2Thrombosis (Thrombus)
09/2020 - 12/2019
2Non-alcoholic Fatty Liver Disease
07/2020 - 01/2018
1Hypophosphatemia
02/2021
1Neoplasm Metastasis (Metastasis)
10/2020
1Tumor Lysis Syndrome
10/2020
1Residual Neoplasm
07/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2020
1Stomach Neoplasms (Stomach Cancer)
01/2020
1Inflammation (Inflammations)
10/2019
1Alcoholic Fatty Liver
10/2019
1Neoplasms, Cystic, Mucinous, and Serous
04/2019
1Chronic Pancreatitis
04/2019
1Renal Insufficiency (Renal Failure)
02/2019
1Reinfection
02/2019
1Infections
01/2019
1Cholangiocarcinoma
11/2018
1Drug-Related Side Effects and Adverse Reactions
12/2015
1Liver Neoplasms (Liver Cancer)
04/2014
1Meniere Disease (Menieres Disease)
05/2008

Drug/Important Bio-Agent (IBA)

6AntigensIBA
01/2022 - 01/2016
6Peptides (Polypeptides)IBA
01/2022 - 08/2015
3Sorafenib (BAY 43-9006)FDA Link
02/2021 - 11/2014
3EpitopesIBA
01/2020 - 01/2018
2Protein Subunit VaccinesIBA
01/2022 - 12/2015
2Fetal Proteins (Fetoprotein)IBA
01/2020 - 01/2017
2Messenger RNA (mRNA)IBA
04/2019 - 01/2007
2CytokinesIBA
01/2019 - 01/2007
2squamous cell carcinoma-related antigenIBA
11/2018 - 01/2017
2Multidrug Resistance-Associated ProteinsIBA
11/2018 - 12/2015
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2018 - 08/2015
1lenvatinibIBA
02/2021
1regorafenibIBA
02/2021
1NivolumabIBA
10/2020
1Immune Checkpoint InhibitorsIBA
10/2020
1AnticoagulantsIBA
09/2020
1Fatty Acids (Saturated Fatty Acids)IBA
07/2020
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2020
1danaparoid (Orgaran)FDA Link
12/2019
1palmitoleic acidIBA
10/2019
1RNA (Ribonucleic Acid)IBA
04/2019
1paritaprevirIBA
02/2019
1Ritonavir (Norvir)FDA Link
02/2019
1ombitasvirIBA
02/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1EnzymesIBA
11/2018
1InterferonsIBA
11/2018
1Carcinoembryonic AntigenIBA
11/2018
1KinesinsIBA
11/2018
1Epithelial Cell Adhesion MoleculeIBA
11/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2018
1GlypicansIBA
11/2018
1Mucin 5ACIBA
11/2018
1Ethanol (Ethyl Alcohol)IBA
01/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017
1Neoplasm Antigens (Tumor Antigens)IBA
04/2014
1HLA-DR Antigens (HLA-DR)IBA
08/2013
1SteroidsIBA
05/2008
1Thymidine KinaseIBA
01/2007
1ChemokinesIBA
01/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2007
1Immunomodulating AgentsIBA
01/2007
1Interleukin-18 (Interleukin 18)IBA
01/2007
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2007
1Interleukin-12 (IL 12)IBA
01/2007

Therapy/Procedure

7Immunotherapy
01/2021 - 08/2014
5Therapeutics
02/2021 - 04/2014
4Drug Therapy (Chemotherapy)
01/2021 - 11/2014
2Radiofrequency Ablation
07/2020 - 04/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2020
1Liver Transplantation
02/2019